July 23rd 2025
Apnimed's first-in-class anti-apneic AD109 increases upper airway muscle tone during sleep; the company plans to file an NDA with the FDA in early 2026.
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
Surv.AI Says: Real-World Insights Into the Journey for Patients With Pulmonary Arterial Hypertension
View More
Advances In™: Moving Care Forward in SCLC with DLL3 Targeting Bispecific T-Cell Engagers
View More
Differentiating Adverse Events for Antibody-Drug Conjugates Across Solid Tumor Management
View More
A New Era of Targeted Therapy for Advanced NSCLC: Exploring Future Directions for Bispecific Antibodies and AD...
September 6, 2025
Register Now!
What’s Next for HER2- and TROP2-Directed ADCs in Lung Cancer: How Emerging Trial Data will Impact our Clinics Today, and Tomorrow….
View More
Do We Have Sea Change in Small Cell Lung Cancer? What Recent Clinical Trial Data Tell Us About Treatment Decision-Making in Real-World Settings, What’s Next for Emerging Novel Strategies
View More
Community Practice Connections™: 25th Annual International Lung Cancer Congress
View More
Community Practice Connections™: 8th Annual School of Nursing Oncology™
View More
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
Virtual Tumor Board for the Onco-Nurse: Improving Outcomes in SCLC Treatment and AE Management
View More
Cases & Conversations™: Integrating Novel Approaches to Treatment in First-line ALK+ mNSCLC – Enhancing Patient Outcomes with Real World Multidisciplinary Strategies
View More
Transforming Treatment in Small Cell Lung Cancer: How Recent Trials Are Shaping Treatment Decision-Making and Future Therapies
View More
Burst CME™: Addressing Diagnostic Challenges and Identifying Targets for Treatment in LCNEC-L
View More
Burst CME™: Exploring Diagnosis and Testing Innovations for Targetable Mutations in SCLC
View More
Burst CME™: Advanced Diagnostic and Testing Approaches for Mutation-Targetable Management of NSCLC
View More
2nd Annual Hawaii Cancer Conference
January 24-25, 2026
Register Now!
23rd Annual Winter Lung Cancer Conference®
January 23-25, 2026
Register Now!
Future Directions in Treating SCLC and LCNEC-L: The Impact of DLL3
View More
Burst CME™: The Role of HER2 in NSCLC and Implications for Emerging Treatment Strategies
View More
42nd Annual CFS: Chemotherapy Foundation Symposium®: Innovative Cancer Therapy for Tomorrow
View More
Community Practice Connections™: 19th Annual New York Lung Cancers Symposium®
View More
A Breath of Strength: Managing Cancer Associated LEMS and Lung Cancer as One
View More
Striking the Right Nerve: Managing Cancer Associated LEMS in Lung Cancer Patients
View More
3rd Annual Hawaii Lung: A Multidisciplinary Case-Based Conference
View More
What caused recurrent pneumonia and hemoptysis in this woman?
A 53-year-old woman presented to the emergency department complaining of substernal chest pain that awoke her from sleep. The chest pain was associated with left shoulder numbness, radiating to her back, and was partially alleviated with sublingual nitroglycerin. During this episode, the patient had a cough productive of yellow phlegm and one instance of cough productive of 1 tbs of bright red blood.
Bronchial thermoplasty for managing asthma: An update on efficacy
June 1st 2007Bronchial thermoplasty is a procedure designed to reduce airway smooth muscle mass and, as a result, reduce bronchoconstriction in persons with asthma. In this procedure, radiofrequency current is applied to the walls of the central airways during a series of bronchoscopies. The results of a randomized controlled study conducted in 11 centers in 4 countries suggest that this intervention is beneficial.
Is there any way to improve adherence to asthma controller therapy?
May 1st 2007Nonadherence with asthma controller medication is a common problem that increases the risk of asthma-related hospitalizations and emergency department visits. Although strategies to improve adherence have often been unsuccessful, it is clear that engaging patients in asthma self-management is one of the keys.
Is obesity really a risk factor for asthma?
May 1st 2007Obesity is a well-known risk factor for many diseases. Now it looks like asthma can be added to the list. A meta-analysis that was conducted by Beuther and Sutherland indicated that being overweight is associated with a 50% increase in the incidence of asthma. The risk applies to both men and women.
COPD and mood disorders, part 2:Sleep problems
April 1st 2007Sleep complaints are common in patients with chronic obstructive pulmonary disease (COPD). Many patients complain of morning tiredness, early awakenings, difficulty in falling asleep, restlessness, and daytime sleepiness. Functional status may eventually be impaired by the resulting chronic fatigue that is compounded by dyspnea.
Using the Pneumonia Severity Index to guide outpatient treatment
March 1st 2007The Pneumonia Severity Index (PSI), which categorizes patients into 5 groups according to risk of short-term mortality, is used at some centers to determine which patients with community-acquired pneumonia can be safely treated as outpatients. Is this a reasonable practice? Yes, according to a multicenter study conducted in France, which found that use of the PSI in emergency departments (EDs) is associated with a greater likelihood of low-risk patients being treated as outpatients, without compromising patient safety.
The influenza vaccine may do more than just prevent flu-related deaths
March 1st 2007The influenza vaccine not only reduces the morbidity and mortality of influenza, it also reduces the risk of death in adults hospitalized with community-acquired pneumonia (CAP). Spaude and colleagues found that this protective effect covered in-hospital all-cause mortality, even after adjustment for pneumococcal vaccination status and the presence of comorbidities.
Managing acute severe asthma, part 1: What therapies to try, and when
February 1st 2007The initial assessment of acute severe asthma includes confirmation of the diagnosis and rapid assessment of mental status and degree of respiratory distress. The severity of airflow obstruction is best determined by forced expiratory volume in 1 second or peak expiratory flow rate. While inhaled ß2-agonists are the initial therapy, the combination of ipratropium and a ß2-agonist can enhance results in some patients. There also is evidence that inhaled corticosteroids can lead to a more rapid improvement in pulmonary function. (J Respir Dis. 2007;28(2):57-64)
Combination Therapy Reduces COPD Exacerbations
January 15th 2007FRANKFURT, Germany -- Therapy with inhaled corticosteroids plus a long-acting bronchodilator appears to significantly improve exacerbations and other outcomes for chronic obstructive pulmonary disease (COPD), according to German researchers.
Acute lymphoblastic leukemia presenting with an acute fibrinous and organizing pneumonia
January 1st 2007The authors report a case of adult-onset acute lymphoblastic leukemia (ALL) presenting with a right upper lobe infiltrate associated with acute fibrinous and organizing pneumonia (AFOP), which resolved spontaneously during the course of chemotherapy.